Cipla Q3 profit up 15% to Rs328 crore1 min read 12 Feb 2015, 07:25 PM IST
Sales grew 6.5% to `2,765 crore, driven mainly by domestic demand
Mumbai: Yusuf Hamied-led Indian generic drug maker Cipla Ltd posted 15.3% rise in net profit at ₹ 328 crore in the December quarter compared with ₹ 284 crore a year ago. Sales grew 6.5% to ₹ 2,765 crore, driven mainly by domestic demand.
Select your Category